Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“We will have several major meetings with FDA to address the credentialing of therapists, whether research sites and potential psychedelic clinics need a doctor on site or on call, whether our protocol to study MDMA and self-compassion will be allowed and limited to participants from the MDMA Therapy Training Program, and the prospect of filing a New Drug Application (NDA) based on the outstanding results of our first Phase 3 study.”
· From the Desk of Rick Doblin, Ph.D. – Winter 2021 · own post

Winter 2021 column, 'key challenges for 2021' list. Expected FDA meetings on therapist credentialing, physician presence at clinics, a self-compassion MDMA protocol, and possibly filing an NDA on one Phase 3 study.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.